Astrana HealthvsRTX

ASTH and RTX stock compared: price, dividend, valuation and results, from SEC filings.

ASTH

Astrana Health Inc.

$31.80

Value $1.8B

+0.09%
ASTH's page

Astrana Health (ASTH) has a market value of $1.8B and RTX (RTX) $266B. Over the last year, with dividends, ASTH moved +35.0% and RTX +13.4%. The P/E is 33.3 for ASTH and 31.7 for RTX. Dividend yield: ASTH 0.09%, RTX 1.42%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ASTH$1.8B

    RTX$266B

    RTX is 151 times ASTH

  • Revenue, 12 months

    ASTH$3.9B

    RTX$96.0B

    RTX is 25 times ASTH

  • Net income, 12 months

    ASTH$53M

    RTX$8.4B

    RTX is 158 times ASTH

  • Operating margin

    ASTH3.1%

    RTX11.8%

    8.7 points apart

  • ROIC

    ASTH4.5%

    RTX8.8%

    4.3 points apart

  • P/E

    ASTH33.3

    RTX31.7

    About the same

  • Dividend yield

    ASTH0.1%

    RTX1.4%

    1.3 points apart

  • 5-year return

    ASTH-71.1%

    RTX+148.8%

    219.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ASTH-71.1%

RTX+148.8%

10020020222023202420252026
Returns by period
PeriodASTHWith dividendsRTXWith dividends
1 year since November 12, 2025+35.0%Price +35.0%+13.4%Price +11.8%
3 years since November 13, 2023+1.4%+0.5% a yearPrice +1.4%+157.0%+37.0% a yearPrice +142.1%
5 years since November 12, 2021-71.1%-22.0% a yearPrice -71.1%+148.8%+20.0% a yearPrice +123.5%
10 years since November 15, 2016+606.7%+21.6% a yearPrice +606.7%+268.0%+13.9% a yearPrice +193.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ASTHAstrana HealthRTXRTX

Valuation

ASTHRTX
Valuation
Price$31.80$198.58
Market value$1.8B$266B
Enterprise value (EV)$2.3B$294B
P/E33.331.7
P/E, 5-year median35.033.6
P/B2.13.9
EV/EBIT19.026.0
Free cash flow yield5.6%3.6%

Results and growth

ASTHRTX
Results and growth
Revenue, 12 months$3.9B$96.0B
Net income, 12 months$53M$8.4B
Free cash flow, 12 months$99M$9.5B
Earnings per share, 12 months$0.96$6.16
Revenue growth, year on year56.4%9.7%
Revenue growth a year, past+35.9%over 5 years+9.4%over 5 years
EPS growth a year, past-14.5%over 5 years–

Margins and returns on capital

ASTHRTX
Margins and returns on capital
Gross margin11.0%–
Operating margin3.1%11.8%
Net margin1.4%8.8%
ROIC4.5%8.8%
ROE6.6%12.7%

Balance sheet

ASTHRTX
Balance sheet
Cash$396M$9.9B
Total debt$977M$38.9B
Net debt / EBITDA3.21.8
Interest cover1.9×–

Dividends and buybacks

ASTHRTX
Dividends and buybacks
Dividend yield0.1%1.4%
Dividend per share, 12 months$0.03$2.82
Dividend growth a year, past–+4.3%over 5 years
Buyback yield1.5%0.0%
Shareholder yield1.5%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ASTH or RTX

Didn't find what you were looking for?

Ask us
Which is bigger, Astrana Health or RTX?

By market value, RTX ($266B) is about 150.6 times Astrana Health ($1.8B), at today's prices.

How did ASTH and RTX stock do over the last 10 years?

Since November 15, 2016, ASTH's price moved +606.7% and RTX's +193.0%. With dividends: ASTH +606.7% (+21.6% a year), RTX +268.0% (+13.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, ASTH or RTX?

The dividend yield at today's price is 0.09% for Astrana Health and 1.42% for RTX. Over the last twelve months they paid $0.03 and $2.82 per share.

What is the P/E of ASTH and RTX?

At today's price, the P/E is 33.3 for ASTH and 31.7 for RTX. The median of the last five years was 35.0 and 33.6, which shows where each stands against its own past.

Which has the higher profit margins, Astrana Health or RTX?

Over the last twelve months, the net margin was 1.4% for Astrana Health and 8.8% for RTX, and the operating margin 3.1% and 11.8%. Revenue was $3.9B and $96.0B.

Which is the better investment, Astrana Health or RTX?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.